myelomasociety.org
Category: Business
99
/ 100 Trust Score
Based on scan findings at the time of analysis
No Threats Found
Screenshot of myelomasociety.org
Captured Aug 17, 2026
https://myelomasociety.org
16 years
Not Ranked - This website does not appear in the Tranco top list
Not listed (91 checked)
✓ Valid (TLS)
Google Cloud (us-east1)
North Charleston, United States
nginx
WordPress
104.196.208.135
Domain & WHOIS Information
Registrar
Squarespace Domains II LLC
Registered
December 16, 2009
Expires
December 16, 2026
Name Servers
ns-cloud-a2.googledomains.com
DNSSEC
Signed
Hosting
Google Cloud (us-east1)
Reputation & Threat Check
91 security engines checked
File Scan Summary
Powered by Quttera Engine
61 files scanned
No threats
61
Low Risk
0
Medium Risk
0
High Risk
0
No threats
Low Risk
Medium Risk
High Risk
www.myelomasociety.org.http-redirect
96 B
No threats
www.myelomasociety.org/?page_id=2928&preview=true
217.2 KB
No threats
www.myelomasociety.org/about%3Ablank
60 B
No threats
www.myelomasociety.org/#
312.7 KB
No threats
www.myelomasociety.org/education/#
145.0 KB
No threats
www.myelomasociety.org/imsound/#
156.2 KB
No threats
www.myelomasociety.org/translational-research-award/#
220.5 KB
No threats
www.myelomasociety.org/donate/#
183.9 KB
No threats
www.myelomasociety.org/publications/#
145.3 KB
No threats
www.myelomasociety.org/glo-ims/#
142.2 KB
No threats
Show 51 more...
www.myelomasociety.org/events/#
156.3 KB
No threats
www.myelomasociety.org/advocacy/about%3Ablank
60 B
No threats
www.myelomasociety.org/advocacy/#
142.6 KB
No threats
www.myelomasociety.org/awards/about%3Ablank
60 B
No threats
www.myelomasociety.org/awards/#
142.7 KB
No threats
www.myelomasociety.org/contact/#
141.6 KB
No threats
www.myelomasociety.org/ims-news-room/#
144.0 KB
No threats
www.myelomasociety.org/ims-connect/#
145.2 KB
No threats
www.myelomasociety.org/meeting-materials/#
142.0 KB
No threats
www.myelomasociety.org/about-us/about%3Ablank
60 B
No threats
www.myelomasociety.org/about-us/#
144.3 KB
No threats
www.myelomasociety.org/grants/#
143.8 KB
No threats
www.myelomasociety.org/renew-membership/#
202.5 KB
No threats
www.myelomasociety.org/career-development-award/#
185.6 KB
No threats
www.myelomasociety.org/membership/#
142.7 KB
No threats
www.google.com/recaptcha/api.js?hl=en&&ver=7.0.4#038;render=explicit
976 B
No threats
player.vimeo.com/video/1122004834?h=91c3f1bf02
5.0 KB
No threats
www.myelomasociety.org/feed/mp3/#
34.1 KB
No threats
www.myelomasociety.org/events/8th-immune-effector-cell-therapies-in-multiple-myeloma-workshop/#
143.3 KB
No threats
www.myelomasociety.org/events/23rd-ims-annual-meeting/#
147.7 KB
No threats
www.myelomasociety.org/events/novel-immune-therapies-workshop/#
144.8 KB
No threats
www.myelomasociety.org/events/ims-community-webinar-series-optimizing-the-use-of-adcs-and-tcrts/#
149.2 KB
No threats
www.myelomasociety.org/events/fda-ims-joint-workshop-defining-patient-populations-for-clinical-trials-in-multiple-myeloma/#
146.8 KB
No threats
www.myelomasociety.org/advocacy/tmap/about%3Ablank
60 B
No threats
www.myelomasociety.org/advocacy/tmap/#
144.4 KB
No threats
www.myelomasociety.org/awards/waldenstrom-award/about%3Ablank
60 B
No threats
www.myelomasociety.org/awards/waldenstrom-award/#
146.8 KB
No threats
www.myelomasociety.org/awards/ken-anderson-young-investigator-award/about%3Ablank
60 B
No threats
www.myelomasociety.org/awards/ken-anderson-young-investigator-award/#
146.6 KB
No threats
www.myelomasociety.org/awards/bart-barlogie-young-investigator-award/about%3Ablank
60 B
No threats
www.myelomasociety.org/awards/bart-barlogie-young-investigator-award/#
146.5 KB
No threats
www.myelomasociety.org/award/a-scalable-manufacturing-platform-for-externally-controllable-universal-car-t-cell-products/#
147.3 KB
No threats
www.myelomasociety.org/officers/masahiro-abe-md-phd/#
145.3 KB
No threats
www.myelomasociety.org/officers/kenneth-anderson-md/#
146.6 KB
No threats
www.myelomasociety.org/officers/suzanne-lentzsch-md-phd/#
146.8 KB
No threats
www.myelomasociety.org/officers/katja-weisel-md/#
147.0 KB
No threats
www.myelomasociety.org/officers/19271/#
146.1 KB
No threats
www.myelomasociety.org/officers/chandramouli-nagarajan-mbbs-frcpedin-frcpathuk/#
145.6 KB
No threats
www.myelomasociety.org/officers/philippe-moreau-md/#
145.2 KB
No threats
www.myelomasociety.org/officers/elena-zamagni-md-phd/#
146.5 KB
No threats
www.myelomasociety.org/officers/noopur-s-raje-md/#
145.0 KB
No threats
www.myelomasociety.org/officers/nikhil-c-munshi-md/#
147.3 KB
No threats
www.myelomasociety.org/officers/jesus-san-miguel-md-phd/#
145.7 KB
No threats
www.myelomasociety.org/officers/shaji-kumar-md/#
144.6 KB
No threats
www.myelomasociety.org/officers/maria-victoria-mateos-md-phd/#
145.9 KB
No threats
www.myelomasociety.org/officers/saad-z-usmani-md-mba-fcap/#
146.6 KB
No threats
www.myelomasociety.org/officers/robert-a-kyle-md/#
145.8 KB
No threats
www.myelomasociety.org/about-us/officers/about%3Ablank
60 B
No threats
www.myelomasociety.org/about-us/officers/#
151.2 KB
No threats
www.myelomasociety.org/about-us/member-details/about%3Ablank
60 B
No threats
www.myelomasociety.org/about-us/member-details/#
217.2 KB
No threats
External Links & Domains
411
External Links
All Clean
1
Iframes
Clean
27
Referenced Domains
All Clean
0
Flagged Resources
None Detected
http://browsehappy.com/Not flagged
http://myelomasociety.org/about-us/Not flagged
http://myelomasociety.org/about-us/member-details/Not flagged
http://myelomasociety.org/about-us/officers/Not flagged
http://myelomasociety.org/about:blankNot flagged
http://myelomasociety.org/advocacy/Not flagged
http://myelomasociety.org/advocacy/tmap/Not flagged
http://myelomasociety.org/award/a-scalable-manufacturing-platform-for-externally-controllable-universal-car-t-cell-products/Not flagged
http://myelomasociety.org/awards/Not flagged
http://myelomasociety.org/awards/bart-barlogie-young-investigator-award/Not flagged
http://myelomasociety.org/awards/ken-anderson-young-investigator-award/Not flagged
http://myelomasociety.org/awards/waldenstrom-award/Not flagged
http://myelomasociety.org/career-development-award/Not flagged
http://myelomasociety.org/contact/Not flagged
http://myelomasociety.org/donate/Not flagged
Show 396 more...
http://myelomasociety.org/education/Not flagged
http://myelomasociety.org/events/Not flagged
http://myelomasociety.org/events/23rd-ims-annual-meeting/Not flagged
http://myelomasociety.org/events/8th-immune-effector-cell-therapies-in-multiple-myeloma-workshop/Not flagged
http://myelomasociety.org/events/fda-ims-joint-workshop-defining-patient-populations-for-clinical-trials-in-multiple-myeloma/Not flagged
http://myelomasociety.org/events/ims-community-webinar-series-optimizing-the-use-of-adcs-and-tcrts/Not flagged
http://myelomasociety.org/events/novel-immune-therapies-workshop/Not flagged
http://myelomasociety.org/glo-ims/Not flagged
http://myelomasociety.org/grants/Not flagged
http://myelomasociety.org/ims-connect/Not flagged
http://myelomasociety.org/ims-news-room/Not flagged
http://myelomasociety.org/imsound/Not flagged
http://myelomasociety.org/meeting-materials/Not flagged
http://myelomasociety.org/membership/Not flagged
http://myelomasociety.org/officers/19271/Not flagged
http://myelomasociety.org/officers/chandramouli-nagarajan-mbbs-frcpedin-frcpathuk/Not flagged
http://myelomasociety.org/officers/elena-zamagni-md-phd/Not flagged
http://myelomasociety.org/officers/jesus-san-miguel-md-phd/Not flagged
http://myelomasociety.org/officers/katja-weisel-md/Not flagged
http://myelomasociety.org/officers/kenneth-anderson-md/Not flagged
http://myelomasociety.org/officers/maria-victoria-mateos-md-phd/Not flagged
http://myelomasociety.org/officers/masahiro-abe-md-phd/Not flagged
http://myelomasociety.org/officers/nikhil-c-munshi-md/Not flagged
http://myelomasociety.org/officers/noopur-s-raje-md/Not flagged
http://myelomasociety.org/officers/philippe-moreau-md/Not flagged
http://myelomasociety.org/officers/robert-a-kyle-md/Not flagged
http://myelomasociety.org/officers/saad-z-usmani-md-mba-fcap/Not flagged
http://myelomasociety.org/officers/shaji-kumar-md/Not flagged
http://myelomasociety.org/officers/suzanne-lentzsch-md-phd/Not flagged
http://myelomasociety.org/publications/Not flagged
http://myelomasociety.org/renew-membership/Not flagged
http://myelomasociety.org/rwlkndntodz70pncjlz+vs5lfhfs7lixda/nQ6BMfy4NA2JV8GvaNOriauzE38L2WqrHhMJJUcx+XNd2b1cxprmEXCC5WRqcvN4kZNMzea4LDY%3DNot flagged
http://myelomasociety.org/translational-research-award/Not flagged
http://myelomasociety.org/zotknmvcufmka+gcznuu6s0sonmy8vvthz6jnd4wwup4krocefqzpoqm7cr93knvfnyeidjhbj8t7xaehzwvmjntmqex4cl9vwjx0/baf2tMms%3DNot flagged
http://tmap.myelomasociety.org/Not flagged
https://bsky.app/profile/myeloma-society.bsky.socialNot flagged
https://cdn.jsdelivr.net/npm/tsparticles@1.18.3/dist/tsparticles.min.jsNot flagged
https://challenges.cloudflare.com/turnstile/v0/api.js?onload%3DturnstileLoadNot flagged
https://events.jspargo.com/ims26/CUSTOM/DGHOProgram2026.pdfNot flagged
https://events.jspargo.com/ims26/CUSTOM/IMS2026Program.pdf?__hstc%3D113688920.2b677668b1c0d347e01494227127fa6c.1775135324106.1779466033070.1779705887942.56&%3B__hssc%3D113688920.1.1779705887942&%3B__hsfp%3Dbf1414f9ef3b88063871ea845a26dec4Not flagged
https://events.jspargo.com/ims26/CUSTOM/IMSCommunityWebinarCentralAug.pdfNot flagged
https://events.jspargo.com/ims26/CUSTOM/IMSCommunityWebinarCentralJul.pdfNot flagged
https://events.jspargo.com/ims26/CUSTOM/IMSCommunityWebinarEastAug.pdfNot flagged
https://events.jspargo.com/ims26/CUSTOM/IMSCommunityWebinarEastJun.pdfNot flagged
https://events.jspargo.com/ims26/CUSTOM/IMSCommunityWebinarWestAug.pdfNot flagged
https://events.jspargo.com/ims26/CUSTOM/IMSCommunityWebinarWestJul.pdfNot flagged
https://fonts.googleapis.com/css2?family%3DOpen+Sans:ital@0%3B1&%3Bfamily%3DPlayfair+Display:ital,wght@0,400%3B0,700%3B1,400%3B1,700&%3Bdisplay%3DswapNot flagged
https://fonts.gstatic.comNot flagged
https://ims26.myexpoonline.com/homeNot flagged
https://myeloma.wpengine.com/about-us/officers/Not flagged
https://myeloma.wpengine.com/wp-content/uploads/2021/02/COI-Policy-IMS.pdfNot flagged
https://myeloma.wpengine.com/wp-content/uploads/2021/03/IMSAltLogo.pngNot flagged
https://myelomasociety.flexigrant.com/startapplication.aspx?id%3D16381Not flagged
https://myelomasociety.org/grants/ims-career-development-award/Not flagged
https://myelomasociety.org/past-events/Not flagged
https://myelomasociety.org/privacy-policy/Not flagged
https://myelomasociety.org/publications/Not flagged
https://myelomasociety.org/wp-content/uploads/2021/03/PM-COVID-vaccination-in-MM-guidelines-The-Final.pdfNot flagged
https://player.vimeo.com/video/1122004834?h%3D91c3f1bf02Not flagged
https://www.eventcreate.com/e/communitywebinarseries2026Not flagged
https://www.eventcreate.com/e/fda-ims-joint-workshop2024Not flagged
https://www.eventcreate.com/e/imsdgho2026Not flagged
https://www.google.com/recaptcha/api.js?hl%3Den&%3B&%3Bver%3D7.0.4#038%3Brender%3DexplicitNot flagged
https://www.googletagmanager.com/gtag/js?id%3DAW-11265840522Not flagged
https://www.googletagmanager.com/gtag/js?id%3DGT-MK9LQQBNot flagged
https://www.gstatic.com/recaptcha/releases/XOqlk8PL_yVx6IdpLbpXdiLy/recaptcha__en.jsNot flagged
https://www.linkedin.com/company/19160726/admin/dashboard/Not flagged
https://www.myelomasociety.orgNot flagged
https://www.myelomasociety.org/Not flagged
https://www.myelomasociety.org/?p%3D18549Not flagged
https://www.myelomasociety.org/?p%3D18605Not flagged
https://www.myelomasociety.org/?p%3D18607Not flagged
https://www.myelomasociety.org/?p%3D18610Not flagged
https://www.myelomasociety.org/?page_id%3D2928&%3Bpreview%3DtrueNot flagged
https://www.myelomasociety.org/?post_type%3Dpodcast&%3Bp%3D18550&%3Bpreview%3DtrueNot flagged
https://www.myelomasociety.org/about-us/Not flagged
https://www.myelomasociety.org/about-us/member-details/Not flagged
https://www.myelomasociety.org/about-us/member-details/membership-information/Not flagged
https://www.myelomasociety.org/about-us/officers/Not flagged
https://www.myelomasociety.org/advocacy/Not flagged
https://www.myelomasociety.org/advocacy/tmap/Not flagged
https://www.myelomasociety.org/award/a-scalable-manufacturing-platform-for-externally-controllable-universal-car-t-cell-products/Not flagged
https://www.myelomasociety.org/award/amyloid-targeting-car-macrophage-therapy-against-al-amyloidosis/Not flagged
https://www.myelomasociety.org/award/ancestrality-of-genomic-alterations-in-multiple-myeloma-impact-on-the-clonal-evolution-and-on-the-minimal-residual-disease-dynamics/Not flagged
https://www.myelomasociety.org/award/apobec3b-as-a-biomarker-and-therapeutic-vulnerability-in-tp53-aberrant-multiple-myeloma/Not flagged
https://www.myelomasociety.org/award/application-of-mass-spectrometry-for-the-diagnosis-and-monitoring-of-real-life-patients-with-monoclonal-gammopathies/Not flagged
https://www.myelomasociety.org/award/armored-cars-to-overcome-sialylation-mediated-resistance-in-multiple-myeloma/Not flagged
https://www.myelomasociety.org/award/batmman-bone-marrow-adipocytes-in-the-multiple-myeloma-niche/Not flagged
https://www.myelomasociety.org/award/bcl2l1-armored-car-t-cells-overcome-exhaustion-and-enhance-persistence-in-multiple-myeloma/Not flagged
https://www.myelomasociety.org/award/bcma-inkt-car-for-the-treatment-of-multiple-myeloma/Not flagged
https://www.myelomasociety.org/award/biomarkers-for-monoclonal-gammopathy-of-undetermined-significance-mgus-and-multiple-myeloma/Not flagged
https://www.myelomasociety.org/award/bone-marrow-inflammation-as-driver-of-multiple-myeloma-persistence-and-relapse/Not flagged
https://www.myelomasociety.org/award/characterizing-the-emergence-of-t-cell-dysfunction-as-a-cause-of-therapy-failure-and-disease-progression-in-multiple-myeloma/Not flagged
https://www.myelomasociety.org/award/chimeric-antigen-receptor-t-cells-secreting-il-12-and-anti-il-6-to-enhance-responses-in-multiple-myeloma/Not flagged
https://www.myelomasociety.org/award/comprehensive-exploration-of-molecular-pathways-and-biomarkers-in-myeloma-induced-bone-disease-a-multi-omics-approach-for-personalized-therapeutic-management/Not flagged
https://www.myelomasociety.org/award/comprehensive-genomic-and-immune-characterization-of-response-and-resistance-to-daratumumab-based-quadruplet-induction-therapy/Not flagged
https://www.myelomasociety.org/award/convad-cart-next-generation-bcma-cart-cells-with-modular-targeting-capacities/Not flagged
https://www.myelomasociety.org/award/correlation-between-unfolded-protein-response-upr-markers-and-thrombosis-in-multiple-myeloma/Not flagged
https://www.myelomasociety.org/award/deciphering-the-human-plasma-cell-niche-and-its-transformation-in-multiple-myeloma-by-highly-multiplexed-tissue-imaging/Not flagged
https://www.myelomasociety.org/award/defining-the-risk-of-clonal-hematopoiesis-and-therapy-related-myeloid-neoplasms-in-multiple-myeloma-patients-receiving-asct-and-lenalidomide-maintenance/Not flagged
https://www.myelomasociety.org/award/democratizing-multiple-myeloma-car-t-cell-therapy-by-in-situ-programming-of-virus-specific-t-cells/Not flagged
https://www.myelomasociety.org/award/destiny-detecting-spatial-heterogeneity-in-multiple-myeloma-patients-through-a-liquid-biopsy-approach/Not flagged
https://www.myelomasociety.org/award/development-of-an-optimized-dual-targeted-tandem-vh-only-fully-human-car-to-generate-long-term-durable-remission-with-adoptive-cellular-therapy-for-multiple-myeloma/Not flagged
https://www.myelomasociety.org/award/development-of-novel-extracellular-vesicle-ev-exosome-based-treatment-for-multiple-myeloma-therapeutic-potential-of-mir125b-containing-osteoblast-derived-evs/Not flagged
https://www.myelomasociety.org/award/development-of-novel-targeted-therapies-for-multiple-myeloma/Not flagged
https://www.myelomasociety.org/award/discover-nutrients-understanding-the-relationship-between-nutrition-and-microbiome-in-mm/Not flagged
https://www.myelomasociety.org/award/discovering-and-targeting-unprecedented-mitochondrial-vulnerabilities-against-multiple-myeloma/Not flagged
https://www.myelomasociety.org/award/dissect-the-mechanisms-by-which-cst6n137d-enhances-the-efficacy-of-car-t-cell-therapy-in-myeloma/Not flagged
https://www.myelomasociety.org/award/dissecting-and-appraising-novel-mitochondrial-vulnerabilities-against-multiple-myeloma/Not flagged
https://www.myelomasociety.org/award/dissecting-the-functional-role-of-apobec3b-in-multiple-myeloma/Not flagged
https://www.myelomasociety.org/award/dissecting-the-mechanisms-of-multiple-myeloma-mm-resistance-to-natural-killer-nk-cells-and-the-role-of-nk-cells-macrophage-interaction-in-mm-immune-evasion/Not flagged
https://www.myelomasociety.org/award/early-detection-and-intervention-in-smoldering-multiple-myeloma-population-based-screening-and-treatment-edit-smm/Not flagged
https://www.myelomasociety.org/award/evaluating-nkp30-directed-bispecific-nk-cell-engagers-for-multiple-myeloma-therapy/Not flagged
https://www.myelomasociety.org/award/evaluation-of-single-nucleotide-polymorphisms-of-brca1-cdkn1a-tp53bp-and-xrcc1-in-multiple-myeloma-patients-undergoing-hematopoietic-stem-cells-transplant-and-their-association-with-clinical-outcom/Not flagged
https://www.myelomasociety.org/award/evaluation-of-single-nucleotide-variants-in-dna-repair-and-cell-cycle-control-genes-in-multiple-myeloma-patients-undergoing-hematopoietic-stem-cell-transplant-and-their-association-with-clinical-outco/Not flagged
https://www.myelomasociety.org/award/exploiting-translation-control-vulnerabilities-imposed-by-antibody-secretion-in-multiple-myeloma/Not flagged
https://www.myelomasociety.org/award/exploring-apobecs-as-therapeutic-vulnerabilities-in-multiple-myeloma/Not flagged
https://www.myelomasociety.org/award/flow-cytometry-as-a-tool-for-the-study-of-the-tumor-microenvironment-in-multiple-myeloma/Not flagged
https://www.myelomasociety.org/award/functional-screens-on-single-cell-transcriptomes-of-genotypically-defined-minimal-residual-disease-cells-to-unravel-specific-vulnerabilities-of-treatment-resistant-multiple-myeloma-future/Not flagged
https://www.myelomasociety.org/award/gck-a-new-therapeutic-target-for-undruggable-ras-in-myeloma-treatment/Not flagged
https://www.myelomasociety.org/award/gck-inhibition-as-a-new-therapeutical-approach-in-rasmut-myeloma-and-possible-strategy-to-overcome-therapy-resistance/Not flagged
https://www.myelomasociety.org/award/glutamine-metabolism-as-new-marker-and-diagnostic-tool-for-bone-diseases-in-mm-patients/Not flagged
https://www.myelomasociety.org/award/how-to-engage-t-cell-in-myeloma/Not flagged
https://www.myelomasociety.org/award/identify-high-risk-disease-in-multiple-myeloma-through-single-cell-detection-of-highly-proliferative-pr-cells/Not flagged
https://www.myelomasociety.org/award/identifying-mechanisms-of-response-and-resistance-to-bcma-car-t-therapy-in-multiple-myeloma-and-extramedullary-disease/Not flagged
https://www.myelomasociety.org/award/immagine/Not flagged
https://www.myelomasociety.org/award/immune-cell-contribution-to-drug-resistance-in-multiple-myeloma/Not flagged
https://www.myelomasociety.org/award/immunogenomics-guided-adaptive-cellular-therapies-in-multiple-myeloma/Not flagged
https://www.myelomasociety.org/award/immunotherapy-for-multiple-myeloma-a-new-generation-of-chimeric-antigen-receptors-and-immune-checkpoint-blockade/Not flagged
https://www.myelomasociety.org/award/improving-immune-surveillance-in-high-risk-multiple-myeloma-patients/Not flagged
https://www.myelomasociety.org/award/improving-prognosis-of-progression-risk-in-multiple-myeloma-precursors-through-single-cell-sequencing-based-genomic-and-immune-microenvironment-profiling-2/Not flagged
https://www.myelomasociety.org/award/investigating-creb1-signaling-as-a-novel-therapeutic-target-in-multiple-myeloma/Not flagged
https://www.myelomasociety.org/award/investigating-heme-induced-effector-car-t-cells-for-multiple-myeloma-therapy/Not flagged
https://www.myelomasociety.org/award/investigating-the-impact-of-vaccinations-on-the-development-and-course-of-monoclonal-gammopathies-a-comprehensive-analysis/Not flagged
https://www.myelomasociety.org/award/investigating-the-molecular-mechanisms-of-microenvironment-dependent-immune-escape-to-natural-killer-cells-in-myeloma-to-uncover-biomarkers-for-rational-combination-treatment-strategie/Not flagged
https://www.myelomasociety.org/award/investigation-of-the-molecular-mechanism-of-gck-inhibition-as-therapeutic-approach-in-multiple-myeloma/Not flagged
https://www.myelomasociety.org/award/liquid-biopsy-in-myeloma-to-inform-outcome-and-treatment-decisions/Not flagged
https://www.myelomasociety.org/award/modeling-unraveling-and-beating-acquired-resistance-to-bcma-and-gprc5d-targeted-agents-in-multiple-myeloma-2/Not flagged
https://www.myelomasociety.org/award/modeling-unraveling-and-beating-acquired-resistance-to-bcma-and-gprc5d-targeted-agents-in-multiple-myeloma/Not flagged
https://www.myelomasociety.org/award/molecular-characterization-and-therapeutic-targeting-of-protein-kinase-d2-in-t414-multiple-myeloma/Not flagged
https://www.myelomasociety.org/award/multimodal-investigation-of-myeloma-recognizing-t-cells-their-transcriptional-features-and-clinical-relevance/Not flagged
https://www.myelomasociety.org/award/nanobody-based-il-18-armored-bcma-baff-r-dual-car-t-cells-to-overcome-treatment-failure-in-multiple-myeloma/Not flagged
https://www.myelomasociety.org/award/novel-immunotherapy-investigation-and-characterization-of-immune-escape-mechanisms-to-natural-killer-cells-in-multiple-myeloma/Not flagged
https://www.myelomasociety.org/award/optimizing-melphalan-dose-among-older-adults-with-multiple-myeloma-receiving-autologous-stem-cell-transplantation/Not flagged
https://www.myelomasociety.org/award/patterns-of-relapse-from-complete-response-during-different-maintenance-strategies/Not flagged
https://www.myelomasociety.org/award/pnc-27-a-novel-effective-strategy-for-targeting-the-achilles-heel-of-multiple-myeloma/Not flagged
https://www.myelomasociety.org/award/role-of-flow-cytometry-and-especially-its-use-in-the-definition-of-the-measurable-residual-disease-mrd-in-multiple-myeloma/Not flagged
https://www.myelomasociety.org/award/shield-mm-a-modular-multiplex-shrna-platform-to-enhance-functional-persistence-of-academic-anti-bcma-car-t-cells-ari0002h-in-multiple-myeloma/Not flagged
https://www.myelomasociety.org/award/single-cell-dissection-of-autologous-apheresis-products-to-predict-successful-manufacturing-safe-application-and-response-to-chimeric-antigen-receptor-t-cells-in-newly-diagnosed-and-relapsed-myeloma/Not flagged
https://www.myelomasociety.org/award/spatial-and-deep-learning-approaches-to-predict-early-progression-in-smoldering-multiple-myeloma/Not flagged
https://www.myelomasociety.org/award/spatial-and-temporal-tumor-genomic-heterogeneity-in-extramedullary-multiple-myeloma-and-solitary-plasmacytoma-with-minimal-marrow-involvement/Not flagged
https://www.myelomasociety.org/award/systematic-functional-genomics-characterization-of-17p13del-multiple-myeloma/Not flagged
https://www.myelomasociety.org/award/targeting-collagen-lair1-for-improving-multiple-myeloma-therapeutic-efficacy/Not flagged
https://www.myelomasociety.org/award/targeting-inter-organelle-communication-to-arrest-multiple-myeloma/Not flagged
https://www.myelomasociety.org/award/targeting-loss-of-the-tumor-suppressor-tent5c-in-multiple-myeloma/Not flagged
https://www.myelomasociety.org/award/targeting-metabolic-switch-of-high-risk-multiple-myeloma-cells-towards-the-design-of-an-exploratory-approach-for-an-unmet-clinical-need/Not flagged
https://www.myelomasociety.org/award/targeting-tcf3-addiction-in-multiple-myeloma/Not flagged
https://www.myelomasociety.org/award/targeting-tf-cd142-as-a-new-target-for-car-nk-cell-immunotherapy-in-multiple-myeloma/Not flagged
https://www.myelomasociety.org/award/targeting-the-bone-marrow-niche-in-multiple-myeloma/Not flagged
https://www.myelomasociety.org/award/the-development-of-amyloid-subtype-specific-car-phagocytes-for-al-amyloidosis-therapy/Not flagged
https://www.myelomasociety.org/award/the-permissive-immune-microenvironment-is-a-critical-regulator-of-disease-progression-from-smm-to-overt-mm-and-defining-these-alterations-is-critical-for-the-development-of-translational-prognostic-a/Not flagged
https://www.myelomasociety.org/award/transforming-multiple-myeloma-care-in-sub-saharan-africa-developing-a-population-specific-next-generation-sequencing-panel-based-on-long-read-whole-genome-sequencing-to-enhance-treatment-outcomes-in/Not flagged
https://www.myelomasociety.org/award/uncovering-ferroptosis-mediated-immune-escape-in-del17p-multiple-myeloma/Not flagged
https://www.myelomasociety.org/award/unlocking-precision-medicine-in-refractory-multiple-myeloma/Not flagged
https://www.myelomasociety.org/award/usbcar-t-using-crispr-2-0-to-generate-universal-slamf7-bcma-car-t-cells-for-treating-multiple-myeloma/Not flagged
https://www.myelomasociety.org/awards/Not flagged
https://www.myelomasociety.org/awards/bart-barlogie-young-investigator-award/Not flagged
https://www.myelomasociety.org/awards/ken-anderson-young-investigator-award/Not flagged
https://www.myelomasociety.org/awards/waldenstrom-award/Not flagged
https://www.myelomasociety.org/belantamab-mafodotin-bortezomib-and-dexamethasone-vs-daratumumab-bortezomib-and-dexamethasone-in-relapsed-refractory-multiple-myeloma-overall-survival-analysis-and-updated-efficacy-outcomes-of-th/Not flagged
https://www.myelomasociety.org/belantamab-mafodotin-bortezomib-and-dexamethasone-vs-daratumumab-bortezomib-and-dexamethasone-in-relapsed-refractory-multiple-myeloma-overall-survival-analysis-and-updated-efficacy-outcomes-of-th/#Not flagged
https://www.myelomasociety.org/career-development-award/Not flagged
https://www.myelomasociety.org/contact/Not flagged
https://www.myelomasociety.org/development-of-an-academic-car-t-in-mm-the-spanish-experience/Not flagged
https://www.myelomasociety.org/development-of-an-academic-car-t-in-mm-the-spanish-experience/#Not flagged
https://www.myelomasociety.org/do-we-need-pet-ct-to-assess-response-in-mm/Not flagged
https://www.myelomasociety.org/do-we-need-pet-ct-to-assess-response-in-mm/#Not flagged
https://www.myelomasociety.org/donate/Not flagged
https://www.myelomasociety.org/drug-access-in-brazil-equity-actions-between-public-and-private-health-systems/Not flagged
https://www.myelomasociety.org/drug-access-in-brazil-equity-actions-between-public-and-private-health-systems/#Not flagged
https://www.myelomasociety.org/education/Not flagged
https://www.myelomasociety.org/efficacy-and-safety-of-isa-krd-induction-before-response-adapted-consolidation-in-transplant-eligible-newly-diagnosed-multiple-myeloma-an-interim-analysis-of-the-ifm2020-02-midas-study/#Not flagged
https://www.myelomasociety.org/events/Not flagged
https://www.myelomasociety.org/events/23rd-ims-annual-meeting/Not flagged
https://www.myelomasociety.org/events/8th-immune-effector-cell-therapies-in-multiple-myeloma-workshop/Not flagged
https://www.myelomasociety.org/events/fda-ims-joint-workshop-defining-patient-populations-for-clinical-trials-in-multiple-myeloma/Not flagged
https://www.myelomasociety.org/events/ims-community-webinar-series-optimizing-the-use-of-adcs-and-tcrts/Not flagged
https://www.myelomasociety.org/events/novel-immune-therapies-workshop/Not flagged
https://www.myelomasociety.org/feed/mp3/Not flagged
https://www.myelomasociety.org/findings-from-the-australian-and-new-zealand-myeloma-and-related-diseases-registry/Not flagged
https://www.myelomasociety.org/findings-from-the-australian-and-new-zealand-myeloma-and-related-diseases-registry/#Not flagged
https://www.myelomasociety.org/first-results-of-a-phase-1-first-in-human-dose-escalation-study-of-isb-2001-a-bcmaxcd38xcd3-targeting-trispecific-antibody-in-patients-with-relapsed-refractory-multiple-myeloma-rrmm/Not flagged
https://www.myelomasociety.org/first-results-of-a-phase-1-first-in-human-dose-escalation-study-of-isb-2001-a-bcmaxcd38xcd3-targeting-trispecific-antibody-in-patients-with-relapsed-refractory-multiple-myeloma-rrmm/#Not flagged
https://www.myelomasociety.org/frontline-therapy-for-transplant-ineligible-patients-the-european-perspective/Not flagged
https://www.myelomasociety.org/frontline-therapy-for-transplant-ineligible-patients-the-european-perspective/#Not flagged
https://www.myelomasociety.org/glo-ims/Not flagged
https://www.myelomasociety.org/grants/Not flagged
https://www.myelomasociety.org/grants/ims-awards-for-exemplary-abstracts/Not flagged
https://www.myelomasociety.org/grants/ims-career-development-award/Not flagged
https://www.myelomasociety.org/grants/international-myeloma-society-ims-and-paula-and-rodger-riney-foundation-translational-research-grant/Not flagged
https://www.myelomasociety.org/importance-of-patient-reported-symptoms-and-health-related-quality-of-life-for-drug-approval-in-mm/#Not flagged
https://www.myelomasociety.org/ims-connect/Not flagged
https://www.myelomasociety.org/ims-connect/ims-connect-July-3-2026/Not flagged
https://www.myelomasociety.org/ims-connect/ims-connect-May-1-2026/Not flagged
https://www.myelomasociety.org/ims-connect/ims-connect-May-15-2026/Not flagged
https://www.myelomasociety.org/ims-connect/ims-connect-May-8-2026/Not flagged
https://www.myelomasociety.org/ims-connect/ims-connect-april-10/Not flagged
https://www.myelomasociety.org/ims-connect/ims-connect-april-17-2026/Not flagged
https://www.myelomasociety.org/ims-connect/ims-connect-april-24-2026/Not flagged
https://www.myelomasociety.org/ims-connect/ims-connect-april-3-2026/Not flagged
https://www.myelomasociety.org/ims-connect/ims-connect-december-12-2025/Not flagged
https://www.myelomasociety.org/ims-connect/ims-connect-december-19-2025/Not flagged
https://www.myelomasociety.org/ims-connect/ims-connect-december-5-2025/Not flagged
https://www.myelomasociety.org/ims-connect/ims-connect-february-13/Not flagged
https://www.myelomasociety.org/ims-connect/ims-connect-february-20-2026Not flagged
https://www.myelomasociety.org/ims-connect/ims-connect-february-27-2026Not flagged
https://www.myelomasociety.org/ims-connect/ims-connect-february-6-2026/Not flagged
https://www.myelomasociety.org/ims-connect/ims-connect-january-16-2026/Not flagged
https://www.myelomasociety.org/ims-connect/ims-connect-january-2-2026/Not flagged
https://www.myelomasociety.org/ims-connect/ims-connect-january-23-2026/Not flagged
https://www.myelomasociety.org/ims-connect/ims-connect-january-30-2026/Not flagged
https://www.myelomasociety.org/ims-connect/ims-connect-january-9-2026/Not flagged
https://www.myelomasociety.org/ims-connect/ims-connect-june-12-2026/Not flagged
https://www.myelomasociety.org/ims-connect/ims-connect-june-19-2026/Not flagged
https://www.myelomasociety.org/ims-connect/ims-connect-june-26-2026/Not flagged
https://www.myelomasociety.org/ims-connect/ims-connect-june-5-2026/Not flagged
https://www.myelomasociety.org/ims-connect/ims-connect-march-13-2026/Not flagged
https://www.myelomasociety.org/ims-connect/ims-connect-march-27-2026/Not flagged
https://www.myelomasociety.org/ims-connect/ims-connect-march-6-2026/Not flagged
https://www.myelomasociety.org/ims-connect/ims-connect-may-22-2026/Not flagged
https://www.myelomasociety.org/ims-connect/ims-connect-may-29-2026/Not flagged
https://www.myelomasociety.org/ims-connect/ims-connect-november-14-2025/Not flagged
https://www.myelomasociety.org/ims-connect/ims-connect-november-21-2025/Not flagged
https://www.myelomasociety.org/ims-connect/ims-connect-november-28-2025/Not flagged
https://www.myelomasociety.org/ims-connect/march-20-2026/Not flagged
https://www.myelomasociety.org/ims-news-room/Not flagged
https://www.myelomasociety.org/ims-news-room/a-statement-from-ims-president-philippe-moreau-after-the-ims-myeloma-cure-summit-definitions-metrics-and-milestones/Not flagged
https://www.myelomasociety.org/ims-news-room/international-myeloma-society-asco-and-eha-signal-a-pivotal-moment-in-multiple-myeloma-research/Not flagged
https://www.myelomasociety.org/ims-news-room/international-myeloma-society-convenes-global-cure-summit-to-chart-the-scientific-path-to-a-myeloma-cure/Not flagged
https://www.myelomasociety.org/ims-news-room/international-myeloma-society-launches-national-webinar-series-to-support-community-use-of-emerging-immunotherapies-in-multiple-myeloma/Not flagged
https://www.myelomasociety.org/ims-news-room/international-myeloma-society-opens-abstract-submissions-for-23rd-annual-meeting/Not flagged
https://www.myelomasociety.org/ims-news-room/international-myeloma-to-convene-global-experts-in-warsaw-for-4th-annual-workshop-on-genomics/Not flagged
https://www.myelomasociety.org/imsound/Not flagged
https://www.myelomasociety.org/isatuximab-lenalidomide-bortezomib-and-dexamethasone-induction-therapy-for-transplant-eligible-patients-with-newly-diagnosed-multiple-myeloma-final-progression-free-survival-analysis-of-part-1-of-a/Not flagged
https://www.myelomasociety.org/isatuximab-lenalidomide-bortezomib-and-dexamethasone-induction-therapy-for-transplant-eligible-patients-with-newly-diagnosed-multiple-myeloma-final-progression-free-survival-analysis-of-part-1-of-a/#Not flagged
https://www.myelomasociety.org/login/?action%3Dforgot_passwordNot flagged
https://www.myelomasociety.org/meeting-materials/Not flagged
https://www.myelomasociety.org/membershipNot flagged
https://www.myelomasociety.org/membership/Not flagged
https://www.myelomasociety.org/membership/directory/Not flagged
https://www.myelomasociety.org/membership/ims-journal/Not flagged
https://www.myelomasociety.org/officers/19271/Not flagged
https://www.myelomasociety.org/officers/chandramouli-nagarajan-mbbs-frcpedin-frcpathuk/Not flagged
https://www.myelomasociety.org/officers/elena-zamagni-md-phd/Not flagged
https://www.myelomasociety.org/officers/jesus-san-miguel-md-phd/Not flagged
https://www.myelomasociety.org/officers/katja-weisel-md/Not flagged
https://www.myelomasociety.org/officers/kenneth-anderson-md/Not flagged
https://www.myelomasociety.org/officers/maria-victoria-mateos-md-phd/Not flagged
https://www.myelomasociety.org/officers/masahiro-abe-md-phd/Not flagged
https://www.myelomasociety.org/officers/nikhil-c-munshi-md/Not flagged
https://www.myelomasociety.org/officers/noopur-s-raje-md/Not flagged
https://www.myelomasociety.org/officers/philippe-moreau-md/Not flagged
https://www.myelomasociety.org/officers/robert-a-kyle-md/Not flagged
https://www.myelomasociety.org/officers/saad-z-usmani-md-mba-fcap/Not flagged
https://www.myelomasociety.org/officers/shaji-kumar-md/Not flagged
https://www.myelomasociety.org/officers/suzanne-lentzsch-md-phd/Not flagged
https://www.myelomasociety.org/ongoing-clinical-trials-from-the-nordic-group/Not flagged
https://www.myelomasociety.org/ongoing-clinical-trials-from-the-nordic-group/#Not flagged
https://www.myelomasociety.org/optimal-therapy-for-young-patients-with-high-risk-disease-the-european-point-of-view/Not flagged
https://www.myelomasociety.org/optimal-therapy-for-young-patients-with-high-risk-disease-the-european-point-of-view/#Not flagged
https://www.myelomasociety.org/phase-2-registrational-study-of-anitocabtagene-autoleucel-for-the-treatment-of-patients-with-relapsed-and-or-refractory-multiple-myeloma-preliminary-results-from-the-immagine-1-trial/Not flagged
https://www.myelomasociety.org/phase-2-registrational-study-of-anitocabtagene-autoleucel-for-the-treatment-of-patients-with-relapsed-and-or-refractory-multiple-myeloma-preliminary-results-from-the-immagine-1-trial/#Not flagged
https://www.myelomasociety.org/phase-2-study-of-teclistamab-based-induction-regimens-in-patients-with-transplant-eligible-te-newly-diagnosed-multiple-myeloma-ndmm-results-from-the-gmmg-hd10-dsmm-xx-majestec-5-trial/Not flagged
https://www.myelomasociety.org/phase-2-study-of-teclistamab-based-induction-regimens-in-patients-with-transplant-eligible-te-newly-diagnosed-multiple-myeloma-ndmm-results-from-the-gmmg-hd10-dsmm-xx-majestec-5-trial/#Not flagged
https://www.myelomasociety.org/phase-3-study-of-teclistamab-tec-in-combination-with-lenalidomide-len-and-tec-alone-versus-len-alone-in-newly-diagnosed-multiple-myeloma-ndmm-as-maintenance-therapy-following-autologous-stem-cel/Not flagged
https://www.myelomasociety.org/phase-3-study-of-teclistamab-tec-in-combination-with-lenalidomide-len-and-tec-alone-versus-len-alone-in-newly-diagnosed-multiple-myeloma-ndmm-as-maintenance-therapy-following-autologous-stem-cel/#Not flagged
https://www.myelomasociety.org/prevention-of-infections-during-treatment-with-bispecific-antibodies-and-car-t-cells-in-multiple-myeloma/#Not flagged
https://www.myelomasociety.org/publications/Not flagged
https://www.myelomasociety.org/renew-membership/Not flagged
https://www.myelomasociety.org/resistance-to-bispecific-antibodies/Not flagged
https://www.myelomasociety.org/resistance-to-bispecific-antibodies/#Not flagged
https://www.myelomasociety.org/role-of-tandem-autologous-stem-cell-transplantation-for-the-treatment-of-multiple-myeloma/Not flagged
https://www.myelomasociety.org/role-of-tandem-autologous-stem-cell-transplantation-for-the-treatment-of-multiple-myeloma/#Not flagged
https://www.myelomasociety.org/safety-and-efficacy-of-standard-of-care-ciltacabtagene-autoleucel-cilta-cel-for-relapsed-refractory-multiple-myeloma-rrmm-real-world-experience-with-updated-follow-up/#Not flagged
https://www.myelomasociety.org/single-cell-analyses-of-bone-marrow-immune-microenvironment-in-rrmm-subjects-treated-with-mek1-2-inhibitors-reveal-irf1-mediated-ifn-pdl1-signaling-axes/Not flagged
https://www.myelomasociety.org/single-cell-analyses-of-bone-marrow-immune-microenvironment-in-rrmm-subjects-treated-with-mek1-2-inhibitors-reveal-irf1-mediated-ifn-pdl1-signaling-axes/#Not flagged
https://www.myelomasociety.org/single-cell-rna-sequencing-of-6-million-tumor-and-immune-cells-in-patients-with-plasma-cell-premalignancy-unveils-co-regulation-of-disease-progression-by-tumor-biology-and-immune-dysregulation/#Not flagged
https://www.myelomasociety.org/the-ifm2017-03-phase-3-trial-a-dexamethasone-sparing-regimen-with-daratumumab-and-lenalidomide-for-frail-patients-with-newly-diagnosed-multiple-myeloma/Not flagged
https://www.myelomasociety.org/the-ifm2017-03-phase-3-trial-a-dexamethasone-sparing-regimen-with-daratumumab-and-lenalidomide-for-frail-patients-with-newly-diagnosed-multiple-myeloma/#Not flagged
https://www.myelomasociety.org/translational-research-award/Not flagged
https://www.myelomasociety.org/wp-content/plugins/ajax-search-lite/css/style-simple-red.css?ver%3D4.14.5Not flagged
https://www.myelomasociety.org/wp-content/plugins/ajax-search-lite/css/style.basic.css?ver%3D4.14.5Not flagged
https://www.myelomasociety.org/wp-content/plugins/ajax-search-lite/js/min/plugin/merged/asl.min.js?ver%3D4787Not flagged
https://www.myelomasociety.org/wp-content/plugins/custom-twitter-feeds/css/ctf-styles.min.css?ver%3D2.6.1Not flagged
https://www.myelomasociety.org/wp-content/plugins/google-site-kit/dist/assets/js/googlesitekit-consent-mode-86cb52dcb9f2b27ed244.jsNot flagged
https://www.myelomasociety.org/wp-content/plugins/gravityforms/assets/css/dist/basic.min.css?ver%3D2.10.5Not flagged
https://www.myelomasociety.org/wp-content/plugins/gravityforms/assets/css/dist/theme-components.min.css?ver%3D2.10.5Not flagged
https://www.myelomasociety.org/wp-content/plugins/gravityforms/assets/css/dist/theme.min.css?ver%3D2.10.5Not flagged
https://www.myelomasociety.org/wp-content/plugins/gravityforms/assets/js/dist/scripts-theme.min.js?ver%3D301fdc9aa6144168f3b854c4c2c8f6d3Not flagged
https://www.myelomasociety.org/wp-content/plugins/gravityforms/assets/js/dist/utils.min.js?ver%3D3f278756f0a3032bed328ff6a9f6c01dNot flagged
https://www.myelomasociety.org/wp-content/plugins/gravityforms/assets/js/dist/vendor-theme.min.js?ver%3D7c651d0ba638ce98b9c65141edddd567Not flagged
https://www.myelomasociety.org/wp-content/plugins/gravityforms/js/conditional_logic.min.js?ver%3D2.10.5Not flagged
https://www.myelomasociety.org/wp-content/plugins/gravityforms/js/gravityforms.min.js?ver%3D2.10.5Not flagged
https://www.myelomasociety.org/wp-content/plugins/gravityforms/js/jquery.json.min.js?ver%3D2.10.5Not flagged
https://www.myelomasociety.org/wp-content/plugins/gravityforms/js/placeholders.jquery.min.js?ver%3D2.10.5Not flagged
https://www.myelomasociety.org/wp-content/plugins/gravityforms/legacy/css/browsers.min.css?ver%3D2.10.5Not flagged
https://www.myelomasociety.org/wp-content/plugins/gravityforms/legacy/css/formreset.min.css?ver%3D2.10.5Not flagged
https://www.myelomasociety.org/wp-content/plugins/gravityforms/legacy/css/formsmain.min.css?ver%3D2.10.5Not flagged
https://www.myelomasociety.org/wp-content/plugins/gravityforms/legacy/css/readyclass.min.css?ver%3D2.10.5Not flagged
https://www.myelomasociety.org/wp-content/plugins/memberpress/css/ui/login.css?ver%3D1.12.17Not flagged
https://www.myelomasociety.org/wp-content/plugins/memberpress/css/ui/theme.css?ver%3D1.12.17Not flagged
https://www.myelomasociety.org/wp-content/plugins/memberpress/js/login.js?ver%3D1.12.17Not flagged
https://www.myelomasociety.org/wp-content/plugins/podlove-podcasting-plugin-for-wordpress/css/admin-font.css?ver%3D4.5.4Not flagged
https://www.myelomasociety.org/wp-content/plugins/podlove-podcasting-plugin-for-wordpress/css/frontend.css?ver%3D1.0Not flagged
https://www.myelomasociety.org/wp-content/plugins/podlove-web-player/js/cache.js?ver%3D5.9.2Not flagged
https://www.myelomasociety.org/wp-content/plugins/podlove-web-player/web-player/embed.js?ver%3D5.9.2Not flagged
https://www.myelomasociety.org/wp-content/themes/myeloma-society/dist/scripts/main.js?ver%3D1778641861Not flagged
https://www.myelomasociety.org/wp-content/themes/myeloma-society/dist/styles/main.css?ver%3D1778641860Not flagged
https://www.myelomasociety.org/wp-content/uploads/2021/01/home3-1000x834.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2021/02/Jesus-San-Miguel-MD-PhD-320x410.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2021/02/Kenneth-Anderson-MD-320x410.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2021/02/Mateos-Maria-Victoria-320x410.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2021/02/Nikhil-C.-Munshi-MD-320x410.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2021/02/Philippe-Moreau-MD-320x410.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2021/02/Raje-Noopur-1-320x410.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2021/02/Robert-A.-Kyle-MD-320x410.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2021/02/Shaji-Kumar-MD-320x410.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2021/03/IMSMainLogo.pngNot flagged
https://www.myelomasociety.org/wp-content/uploads/2021/03/cropped-IMSAltLogo-180x180.pngNot flagged
https://www.myelomasociety.org/wp-content/uploads/2021/03/cropped-IMSAltLogo-192x192.pngNot flagged
https://www.myelomasociety.org/wp-content/uploads/2021/03/cropped-IMSAltLogo-32x32.pngNot flagged
https://www.myelomasociety.org/wp-content/uploads/2022/09/211125_SANOFI_LOGO_RGB.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2022/09/AbbVie-Logo_Blue-002.pngNot flagged
https://www.myelomasociety.org/wp-content/uploads/2022/11/GENE_LOCKUP_Primary_FullColor_RGB-002-2-1.pngNot flagged
https://www.myelomasociety.org/wp-content/uploads/2022/11/legend_logo_533x260-002-1.pngNot flagged
https://www.myelomasociety.org/wp-content/uploads/2023/08/shutterstock_775583896-745x419.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2023/10/2.-AbbVie-Logo-DigitalAbbVieLogo_Preferred-DigitalAbbVieLogo_Preferred_Black_TransparentBack-300x52.pngNot flagged
https://www.myelomasociety.org/wp-content/uploads/2023/10/20th-IMS-Annual-Meeting-Abstract-Book.pdfNot flagged
https://www.myelomasociety.org/wp-content/uploads/2023/10/Abe-Headshot-320x410.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2023/10/FDAIMSWorkshop2024Program-1.pdfNot flagged
https://www.myelomasociety.org/wp-content/uploads/2023/10/FDA_IMS-Joint-Wkshp-780x390-1-745x390.pngNot flagged
https://www.myelomasociety.org/wp-content/uploads/2023/10/JNJ_Logo_SingleLine_Red_RGB-1-002-300x28.pngNot flagged
https://www.myelomasociety.org/wp-content/uploads/2023/10/ReGEN_Science-Tagline-002-300x70.pngNot flagged
https://www.myelomasociety.org/wp-content/uploads/2023/10/Slide1-300x169.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2023/10/Usmani.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2023/10/Zamagni-Elena-320x410.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2023/10/bms_logo_150_rgb_pos-300x42.pngNot flagged
https://www.myelomasociety.org/wp-content/uploads/2024/04/Ochi-headshot-1.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2024/05/TMAP-Logo-scaled.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2024/06/IMSound-Logo-for-site-scaled.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2024/06/IMSound-Logo-scaled.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2024/07/IMSound-Logo-only-v2.pngNot flagged
https://www.myelomasociety.org/wp-content/uploads/2024/07/TMAP-Logo-scaled.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2024/08/JNJ_Logo_SingleLine_Red_CMYK-300x28.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2024/08/Practical-Insights-2024_1080-x-1080.jpg2_-745x419.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2024/10/AZ_RGB_H_COL-300x73.pngNot flagged
https://www.myelomasociety.org/wp-content/uploads/2024/10/IMSAnnual2024Abstracts.pdfNot flagged
https://www.myelomasociety.org/wp-content/uploads/2024/10/Sanofi-logo-RGB-JPG-300x138.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2024/10/bms_logo_300_rgb_pos-300x41.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2025/04/GSK_Logo_Full_Colour_RGB-300x169.pngNot flagged
https://www.myelomasociety.org/wp-content/uploads/2025/07/Full_Caribou_Logo_Dual_R-300x91.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2025/09/25IMS_004103-1-scaled.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2025/09/25IMS_004129-1-scaled.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2025/09/25IMS_004148-2-scaled.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2025/09/Chandramouli_Nagarajan.pngNot flagged
https://www.myelomasociety.org/wp-content/uploads/2025/09/IMS-Program-and-Initiatives-2025-Prf9.pdfNot flagged
https://www.myelomasociety.org/wp-content/uploads/2025/09/IMSAnnual2025Abstracts.pdfNot flagged
https://www.myelomasociety.org/wp-content/uploads/2025/09/Lentzsch-Suzanne-320x410.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2025/09/Natalia-Schutz.pngNot flagged
https://www.myelomasociety.org/wp-content/uploads/2025/09/Weisel-Katja-320x410.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2025/10/24IMSADA_01640-1000x750.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2025/10/25IMS_001072_Panel_Precursor-1000x750.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2025/10/25IMS_001681_Panel_Perrot-1000x568.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2025/10/25IMS_003079_Audience-1000x696.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2025/10/25IMS_004033_Poster-1000x750.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2025/12/GILEAD_KITE_Logo_Horiz_RGB_012622-300x93.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2025/12/IMS-2026-Graphics_940x789-745x419.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2025/12/Pfizer_BU_Oncology_Color_RGB-300x142.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2025/12/Roche_Logo_800px_Blue_RGB_Roche_Logo_RGB-3-300x156.pngNot flagged
https://www.myelomasociety.org/wp-content/uploads/2026/03/Abbvie-Community-300x114.pngNot flagged
https://www.myelomasociety.org/wp-content/uploads/2026/03/Community-Webinar-Graphics_940x789-1-745x419.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2026/03/Slide1-1-300x169.pngNot flagged
https://www.myelomasociety.org/wp-content/uploads/2026/03/Slide1-300x169.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2026/03/images-e1773728008617-300x60.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2026/05/IMS-GLO-Promos_1080x1080-1000x1000.jpgNot flagged
https://www.myelomasociety.org/wp-content/uploads/2026/07/IMS-2026-Media-Briefing-The-State-of-Multiple-Myeloma-Cure.pdfNot flagged
https://www.myelomasociety.org/wp-includes/css/dashicons.min.css?ver%3D7.0.4Not flagged
https://www.myelomasociety.org/wp-includes/js/dist/a11y.min.js?ver%3Daf934e5259bc51b8718eNot flagged
https://www.myelomasociety.org/wp-includes/js/dist/dom-ready.min.js?ver%3Da06281ae5cf5500e9317Not flagged
https://www.myelomasociety.org/wp-includes/js/dist/hooks.min.js?ver%3D7496969728ca0f95732dNot flagged
https://www.myelomasociety.org/wp-includes/js/dist/i18n.min.js?ver%3D781d11515ad3d91786ecNot flagged
https://www.myelomasociety.org/wp-includes/js/jquery/jquery-migrate.min.js?ver%3D3.4.1Not flagged
https://www.myelomasociety.org/wp-includes/js/jquery/jquery.min.js?ver%3D3.7.1Not flagged
https://www.myelomasociety.org/wp-includes/js/underscore.min.js?ver%3D1.13.8Not flagged
https://www.vanguardngr.com/casino/de/online-casino-ohne-verifizierung/Not flagged
https://x.com/Myeloma_SocietyNot flagged
browsehappy.comNot flagged
bsky.appNot flagged
cdn.jsdelivr.netNot flagged
challenges.cloudflare.comNot flagged
cloud.google.comNot flagged
developers.google.comNot flagged
docs.cloud.google.comNot flagged
events.jspargo.comNot flagged
fonts.googleapis.comNot flagged
fonts.gstatic.comNot flagged
google.comNot flagged
ims26.myexpoonline.comNot flagged
myeloma.wpengine.comNot flagged
myelomasociety.flexigrant.comNot flagged
myelomasociety.orgNot flagged
Show 12 more...
player.vimeo.comNot flagged
support.google.comNot flagged
tmap.myelomasociety.orgNot flagged
vimeo.comNot flagged
www.eventcreate.comNot flagged
www.google.comNot flagged
www.googletagmanager.comNot flagged
www.gstatic.comNot flagged
www.linkedin.comNot flagged
www.myelomasociety.orgNot flagged
www.vanguardngr.comNot flagged
x.comNot flagged
<iframe title%3D"vimeo-player" src%3D"https://player.vimeo.com/video/1122004834?h%3D91c3f1bf02" width%3D"640" height%3D"360" frameborder%3D"0" allowfullscreen%3D"allowfullscreen">Not flagged
myelomasociety.org Overview
Description of myelomasociety.org
myelomasociety.org appears to be the official website of the International Myeloma Society, an organization focused on multiple myeloma research, education, advocacy, and clinical care. The homepage branding, page title, and navigation links indicate a professional association or nonprofit-style organization serving clinicians, researchers, and members of the myeloma community worldwide.
Based on the visible content and linked sections, the site appears to provide information about annual meetings, educational resources, research initiatives, awards, advocacy efforts, membership, and donations. The domain’s long registration history and healthcare/education/advocacy-related classifications are consistent with an established medical society or NGO presence rather than a temporary promotional site.
Safety Assessment for myelomasociety.org
At the time of this scan, no security engines reported detections for this domain, and the malware scan indicated no flagged files among the pages checked. In addition, the domain was not listed by the checked malware and phishing-oriented blacklist databases, and the referenced external links and domains did not show flagged items in the provided scan results.
Other contextual signals also appear favorable. The domain has been registered for many years, the site content matches a healthcare and advocacy-oriented organization, and the screenshot shows a coherent institutional website rather than patterns commonly associated with phishing, fake storefronts, or malware delivery. Based on available data, no threats were detected at the time of this scan.
Technical Description
The site is using a valid SSL/TLS certificate issued by Let's Encrypt, with the certificate shown as current through 2026-10-02. It is hosted on Google Cloud infrastructure in the United States, uses the nginx web server, and its nameservers are configured through Google Domains-related infrastructure.
DNSSEC appears to be enabled and signed, which may help protect DNS integrity. No immediate technical security concerns were evident from the provided scan data, although the exact supported TLS protocol details were not available in this snapshot.
HTTP Redirect Chain
301
https://myelomasociety.org/
200
https://www.myelomasociety.org/
Website Insights
Popularity
Cookies
Not Ranked
Tranco Rank
Not in Top 1M
Rank History (30 days)
No rank data available
3
cookies detected
Essential0
Analytics2
Advertising1
Social0
3
1st party cookies
0
3rd party (trackers)
Dispute This Score
For website owners
Believe this score is inaccurate?
If you are the website owner and believe the scan results contain
errors or false positives, you can submit a dispute for manual review.
Our team typically responds within 1-2 business days.
One more step…
To submit your dispute for
myelomasociety.org, please click
the verification link we just emailed you. Once verified, we'll review
it within 1-2 business days.
This report was generated automatically and is provided for informational
purposes only. Results are based on a point-in-time scan and may contain
false positives or incomplete data. This does not constitute a security
audit or certification. No vendor in the market can guarantee a 100%
detection rate. If you believe this report is inaccurate, please
submit a dispute.
Similar Recently Scanned
Share your experience with this website. Was it safe? Did you encounter any issues?